Bolt Biotherapeutics (BOLT) Shares Issued (2020 - 2025)
Bolt Biotherapeutics (BOLT) posted Shares Issued of $459775.0 for Q4 2025, down 19.52% sequentially from $571308.0 in Q4 2024, and down 19.52% YoY from $571308.0 in Q4 2024.
Bolt Biotherapeutics (BOLT) Shares Issued (2020 - 2025) Analysis & Trends
Bolt Biotherapeutics has reported Shares Issued for 6 years, with the latest figure at $459775.0 in Q4 2025.
- Quarterly Shares Issued fell 19.52% year-over-year to $459775.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $459775.0 (down 19.52% YoY) and the FY2025 annual result came in at $459775.0, down 19.52% from the prior year.
- Shares Issued slipped to $459775.0 in Q4 2025 per BOLT's latest filing, from $571308.0 in the prior quarter.
- Over five years, Shares Issued peaked at $10.7 million in Q4 2023 and troughed at $459775.0 in Q4 2025.
- A 5-year average of $4.9 million and a median of $5.6 million in 2021 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued soared 48.17% in 2023, then sank 94.66% in 2024.
- Over 5 years, Shares Issued stood at $5.6 million in 2021, then rose by 28.5% to $7.2 million in 2022, then surged by 48.17% to $10.7 million in 2023, then tumbled by 94.66% to $571308.0 in 2024, then retreated by 19.52% to $459775.0 in 2025.
- According to Business Quant data, Shares Issued over the past three periods registered $459775.0, $571308.0, and $10.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Bolt Biotherapeutics | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 459,775.00 |
| Dec 31, 2025 | 459,775.00 |
| Dec 31, 2024 | 571,308.00 |
| Dec 31, 2024 | 571,308.00 |
| Dec 31, 2023 | 10.71 Mn |
| Dec 31, 2023 | 10.71 Mn |
| Dec 31, 2022 | 7.23 Mn |
| Dec 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 5.62 Mn |
| Dec 31, 2021 | 5.62 Mn |
| Dec 31, 2020 | 3.80 Mn |
| Dec 31, 2020 | 3.80 Mn |